FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37288511000001100: Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2582391000001113 Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2582401000001111 Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has AMP Solifenacin 10mg tablets (Krka UK Ltd) true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Is a Solifenacin 10mg tablets 250 tablet true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has specific active ingredient Solifenacin succinate true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Solifenacin 10mg tablets (Krka UK Ltd) 250 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start